Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention
10.1016/j.ijcard.2021.05.012
Saved in:
Main Authors: | Bhatt, Deepak L., Kaski, Juan Carlos, Delaney, Sean, Alasnag, Mirvat, Andreotti, Felicita, Angiolillo, Dominick J., Ferro, Albert, Gorog, Diana A., Lorenzatti, Alberto J., Mamas, Mamas, McNeil, John, Nicolau, Jose C., Steg, Philippe Gabriel, Tamargo, Juan, Tan, Doreen, Valgimigli, Marco |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
Elsevier Ireland Ltd
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232599 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016) -
One-year outcomes of patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic
by: Phua, Kailun, et al.
Published: (2021) -
ReoPro Observational Registry (RAPOR): Insights from the multicentre use of abciximab in Asia
by: Poh, K.K., et al.
Published: (2016) -
Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution
by: Liang, M., et al.
Published: (2014)